Skip to content
healthcare.dev
Get a free key

TAZAROTENE

NDC 45802-442, tazarotene, gel, from Padagis Israel Pharmaceuticals Ltd.

Product NDC
45802-442
Status
Listed
Labeler
Padagis Israel Pharmaceuticals Ltd
Dosage form
GEL
Route
TOPICAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA213079
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/45802-442 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • TAZAROTENE1 mg/g

Pharmacologic classes

Retinoid [EPC]; Retinoids [CS]

Package NDCNDC-11Package
45802-442-01458020442011 TUBE in 1 CARTON (45802-442-01) / 100 g in 1 TUBE
45802-442-94458020442941 TUBE in 1 CARTON (45802-442-94) / 30 g in 1 TUBE

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/ffd11dee-4266-4201-9573-1e82c2d30a63

  • NADAC price for package 45802044201

    GET /v1/drugs/nadac/45802044201

  • NADAC price for package 45802044294

    GET /v1/drugs/nadac/45802044294

Use it

Look up 45802-442 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/45802-442 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 45802-442. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.